SlideShare une entreprise Scribd logo
1  sur  8
Télécharger pour lire hors ligne
White Paper

Oligo GEArrays®: The Pathway-Focused DNA
Microarray System for Every Laboratory

By Heather Fox-Brashears, George Quellhorst, Raymond Blanchard, Bill Wang and Sean Yu
SABiosciences
6951 Executive Way
Frederick, MD 21703
+1 (301) 682-9200 Phone
+1 (301) 682-7300 Fax
www.SABiosciences.com
heatherf@SABiosciences.net

ABSTRACT
This paper describes the technology and performance characteristics of the Oligo GEArray® DNA microarray
system. Oligo GEArrays® are an effective alternative to genome-wide microarrays, in that each array is designed
to profile expression of a focused gene panel from a particular biological pathway or disease state. The data
presented in this paper substantiates the sensitivity, reproducibility, and reliability of this innovative approach
to microarray design. The Oligo GEArray’s® flexible protocol options, ease-of-use, and adaptability to any
laboratory setting provide researchers with a robust tool for routine use of microarray technology in everyday
experiments.
Pathway-Focused Oligo GEArrays®

Introduction to Microarray Technology and Oligo GEArrays®
Microarray technology utilizes RNA from cells, tissue, and other biological source materials to
simultaneously determine the expression levels of many genes. Microarrays are composed of a set of distinct,
gene-specific, nucleic acid probes immobilized on a solid support. During a microarray experiment, RNA
is enzymatically converted to labeled cDNA (complementary DNA) or cRNA, and then hybridized to the
immobilized nucleic acid probe. The labeled target bound at each gene-specific spot is typically detected using
chemiluminescent, fluorescent, or radioactive methods. The signal produced at each spot is representative of the
amount of message in the original RNA sample.
Advances in DNA microarray technology have facilitated genome-wide expression profiling with
whole genome microarrays available from companies such as Affymetrix, Agilent or Illumina. While these
microarrays provide a solution for discovery-based research endeavors, the large amount of data produced from
genome-wide arrays requires the use of specialized software and daunting analysis procedures. SABiosciences
pathway-focused, lower-density Oligo GEArray® microarray system provides a more economical and productive
alternative for monitoring a focused panel of genes in a particular biological pathway or disease state. Oligo
GEArrays® are comprised of a nylon membrane support spotted with gene-specific 60-mer oligos for up to 440
different genes. Oligo GEArrays® use as little as 10 pg of total RNA, with a chemiluminescence detection method.
No special equipment is required for the Oligo GEArray® platform, facilitating its easy adoption into any
biological research laboratory. These arrays offer comparable performance to high-density microarray formats
while enabling hypothesis-driven experimental design, relevant data acquisition, and efficient data analysis.

Oligo GEArray Characteristics
The Oligo GEArray® product platform combines expertly designed pathway-specific microarrays and
advanced oligonucleotide probe design with a streamlined labeling, hybridization, and detection protocol
(Figure 1). The distinct advantages of the Oligo GEArray® system are outlined in Table 1. With the combined
benefits of the membranes, reagents, uncomplicated protocol, and the GEArray® Analysis Suite Software, the
Oligo GEArray® product line provides a complete and convenient microarray experiment package for any
laboratory.
Table 1: Features and Benefits of the Oligo GEArray® System
Focused Array Design

Lower-density (113-440 genes) arrays designed by biological pathway or disease state for relevant
data acquisition

Excellent Quality Manufacturing

Carefully-designed mRNA 3’ end biased 60-mer oligonucleotide probes
(Median distance ~160 bases from 3’ end) on a positively-charged nylon membrane with noncontact printing method (10 nL deposition volume)

Easy Target Labeling

One-tube proprietary IVT-based linear RNA amplification  labeling kit using 0.1 to 3 µg of total RNA

Various Detection Method

Single color / channel chemiluminescent detection or X-ray film

Express Protocol

With the HybPlate Array format, you can easily process up to 32 arrays in one day

Straightforward Data Analysis
Software

Web-based software available by subscription

Tel 888-503-3187 (USA)

301-682-9200

Fax 888-465-9859 (USA)

301-682-7300
SABiosciences



HybPlate
Express
Protocol
(Single Day
Experiment)

Standard
HybTube
Protocol
(Two Day
Experiment)

3 hours

How It Works

3 hours

3.5 hours in
Thermoshaker

Overnight in
Hyb Oven

0.75 hours

1.5 hours

0.5 hours

0.5 hours

Preparation of Labeled cRNA with TrueLabelingAMP™ 2.0
Start with as little as
0.1 - 3.0 µg of Total RNA

Amplify
Labeled cRNA
Target

Hybridization and Washing
Simply add cRNA target to the
GEArray and follow the easy
hybridization and wash steps.

ce

urfa

yS
Arra

Signal Development
Detection is as simple as
developing a Western Blot
using chemiluminescence.

Image Aquisition
Use a CCD-camera system to
capture chemiluminescence.
You can also use X-ray film
and a standard desktop scanner.
®

Analysis with GEArray Expression Analysis Suite
Auto-align the gene table for your arrays to the captured
image, select your analysis parameters, and go!
Graphical and tabulated differential gene expression
data is at your fingertips.

Figure 1: Outline of the Oligo GEArray® experimental procedure
Oligo GEArrays are composed of 113-440 gene-specific 60-mer oligos that have been rigorously evaluated
for specificity, sequence complexity, secondary structure, melting temperature, GC content, and distance to 3’
end of transcript. The oligo probes are immobilized on a positively charged, three-dimensional nylon membrane.
The nylon membrane matrix offers distinct advantages over impermeable surfaces such as chips and glass slides,
including larger probe immobilization and increased hybridization and detection area. When combined with
an optimally formulated hybridization solution and sensitive chemiluminescent detection, the Oligo GEArray
membrane maximizes both hybridization efficiency and signal generation.
The choice of two different target labeling kits is an integral part of the Oligo GEArray platform. The
TrueLabeling-AMP™ 2.0 linear amplification and labeling kit is a universal target labeling method specifically
designed to convert total RNA to amplified and labeled cRNA (Step 1, Figure 1). Based on standard in vitro
transcription based methods, the TrueLabeling-AMP™ 2.0 procedure requires fewer enzymatic reactions, only
one purification step, and a significantly shorter protocol as compared to traditional procedures. The biotinylated
cRNA target contains the same 3’ biased sequences as the gene-specific oligonucleotides printed on the array to
Email support@SABiosciences.com

Web www.SABiosciences.com
Pathway-Focused Oligo GEArrays®
enhance efficient hybridization and maximize signal. Only 0.1 to 3 µg of total RNA starting material is required
for the TrueLabeling-AMP 2.0 kit to produce sufficient cRNA for hybridization. When using a consistent amount
of cRNA in the hybridization step, differing amounts of total RNA can be utilized to produce similar microarray
results (Figure 2). The TrueLabeling-PicoAMP™ two-round amplification and labeling kit is designed for very
small samples with as little as 100 picograms of RNA (10 cells), and provides comparable results to the standard
one-round True Labeling-AMP 2.0. In Figure 3, a comparison is shown between microarray results with varying
amounts of input RNA in the two-round TrueLabeling-PicoAMP™ kit, and results obtained with the one-round
True Labeling-AMP kit. The TrueLabeling-PicoAMP™ kit offers an excellent solution for laboratories interested
in performing microarray studies on sources of limited RNA, such as laser capture microdissection (LCM),
Formalin-Fixed Paraffin Embedded (FFPE), or Fine Needle Aspiration Biopsy (FNAB) samples.
Normalized Signal Intensity (SI)
4.00

Log(SI) from 100ng RT-IVT input

3.00
2.00
1.00
0.00
-1.00
-2.00
-3.00
-4.00
y = 1.0102x - 0.1532
2
R = 0.9738

-5.00
-6.00
-6.00

-4.00

-2.00
0.00
2.00
Log(SI) from 3ug RT-IVT input

4.00

Figure 2: Biotinylated cRNA synthesized from different amounts of total RNA produce similar array results. A constant amount (2 µg) of
cRNA generated from differing amounts of total RNA (listed above) was hybridized to separate Oligo GEArray Human Tumor Metastasis
Microarrays (HybTube format, catalog number OHS-028) for 18 hours at 60oC. Hybridization, washing, and chemiluminescent detection
were performed as outlined in the User Manual. A good correlation was observed between the normalized signal intensities obtained with
different total RNA inputs.

1.50

Normalized Signal Intensity (SI)

Log(SI) from 500pg total RNA

1.00

0.50

0.00

-0.50

-1.00

y = 0.9064x + 0.0513
2
R = 0.9336

-1.50
-1.50

-1.00

-0.50

0.00

0.50

1.00

1.50

Log(SI) from 500ng total RNA

Figure 3: Similar microarray performance is observed with 500 pg total RNA starting material with the TrueLabeling-PicoAMP™ kit as
compared to 500 ng total RNA starting material with the TrueLabeling-AMP™ 2.0 kit. Human XpressRef™ Total RNA (500 pg) was used in
the TrueLabeling-PicoAMP™ procedure as outlined in the User Manual. The 1-round TrueLabeling-AMP™ 2.0 amplification and labeling
procedure was performed as outlined in the User Manual with 500 ng of the Human XpressRef™ Total RNA. For the hybridization step, 2 µg
of each cRNA target was hybridized to separate Oligo GEArray® Human Tumor Metastasis Microarrays (HybTube format, catalog number
OHS-028). Hybridization with 2-round cRNA produced a similar pattern and comparable percent present call to the 1-round cRNA. A good
correlation in normalized signal intensity was observed between the two labeling methods.

Tel 888-503-3187 (USA)

301-682-9200

Fax 888-465-9859 (USA)

301-682-7300
SABiosciences



The Oligo GEArray® hybridization protocol, array formats, and detection methods also offer flexibility
and processing options for every laboratory. The traditional HybTube array format is designed for use with the
standard rotisserie-style hybridization ovens. The HybPlate format is ideal for high-throughput applications,
allowing the processing of up to 32 arrays in one day with the use of SABiosciences' specialized GEArray®
Express Thermoshaker. The GEArray® chemiluminescent detection system, optimized for use with the nylon
membrane matrix, offers excellent sensitivity, wide dynamic range (up to 4 orders of magnitude), and versatile
image acquisition options. Chemiluminescent detection provides comparable or better sensitivity and signal as
compared to radioactive detection methods, without the worry of radioactive waste disposal and precautionary
laboratory measures. The array images can be captured using a cooled CCD camera (for best results) or simply
with X-ray film and the use of a desktop scanner. When used with autoradiography film, chemiluminescent
detection methods are generally more sensitive than radioactivity. Array data analysis is facilitated through the
use of SABiosciences' GEArray® Expression Analysis Suite web-based software. This subscription-based software
offers automated, array-specific analytical functions as well as various analysis tools including scatter plots and
hierarchical clustering.
The Oligo GEArray® is a user-friendly, efficient, and focused DNA microarray tool that offers superior
pathway-focused solutions for gene expression studies. The straightforward protocol includes a cRNA
amplification and labeling portion that can be completed in as little as 2.5 hours. In addition, the protocol
provides flexible hybridization options that include a 1-day express procedure (HybPlate format only), and a
simple and safe chemiluminescent detection. Oligo GEArrays® provide a convenient, cost-effective, sensitive, and
pathway-focused alternative to genome-wide microarrays.

Oligo GEArray Performance: Sensitivity, Dynamic Range, Reproducibility, and Reliability
Typical performance parameters for microarray validation include sensitivity and dynamic range,
reproducibility, and reliability (compatibility with real-time PCR results). The Oligo GEArray® system affords
excellent sensitivity, a wide dynamic range (up to 4 orders of magnitude), robust reproducibility, and good
correlation with real-time PCR experiments. Oligo GEArrays® offer similar or better performance as compared to
popular genome-wide array systems (Table 2).

Table 2: Typical System Performance (*based on published Affymetrix technical notes)
Oligo GEArray®

Affymetrix™ GeneChip®*

Sensitivity

As low as 10 fM synthetic target

125 fM

Linear Dynamic Range

 3 orders of magnitude

 3 orders of magnitude

Specificity

60-mers provide superior specificity as
compared to shorter probes

25-mer probes provide less sensitivity that
60-mer or 70-mer probes

Reproducibility

~ 10% CV

10-15% CV

Sample Input

10 pg – 3 µg total RNA

At least 100 ng RNA

Email support@SABiosciences.com

Web www.SABiosciences.com
Pathway-Focused Oligo GEArrays®
To address the qualities of sensitivity and dynamic range, known quantities of labeled synthetic
RNA target were spiked into a labeled human RNA sample for the performance of a series of hybridization
experiments (Figure 4). The Oligo GEArray® exhibits a low-limit of detection in the 10 fM range, as demonstrated
by detection of the target at a spiking ratio of 1:20,000,000. This performance level indicates that the Oligo
GEArray® is an excellent tool for studying low abundance transcripts (less than 10 copies per cell); however,
the wide linear dynamic range allows for the simultaneous, accurate detection of both high and low abundance
messages.
Performance determined by titration of synthetic target

100000

Raw Intensity

R2 = 0.9969
10000
1000

100
noise level

10
0.00

0.01

0.10

1.00

10.00

100.00

Luciferase cRNA (pM)

Figure 4: The Oligo GEArray exhibits a high level of sensitivity and wide linear dynamic range. A firefly luciferase in vitro transcript
was converted to labeled cRNA target using the TrueLabeling-AMP method. Different known amounts of the target (10 fM to 10 pM) were
mixed with a constant amount of labeled cRNA target generated from XpressRef™ Human Universal Reference Total RNA (GA-004). Each
mixture of labeled cRNA target was hybridized to replicate Oligo GEArray® Human Microarrays. The luciferase gene raw signal intensity
was plotted versus the quantity of labeled luciferase cRNA. These results demonstrate that the Oligo GEArray® can detect as little as 10 fM
labeled target with a linear dynamic range of four orders of magnitude (from 0.01 pM to 10 pM).

	
Oligo GEArrays® are manufactured utilizing an advanced, non-contact printing technology that ensures
excellent array print quality and reproducibility. Technical replicates within an experiment generally yield
coefficient of variation values (CVs) of less than 10%. Figure 5 illustrates a representative comparison between
the results of duplicate Oligo GEArrays®. The results demonstrate a high degree of correlation between the data
sets; thus indicating that the Oligo GEArray® system is a robust, reproducible method to reliably detect small, yet
biologically significant changes in gene expression.
100000

Hybridization 1

R2 = 0.9939

10000

1000

100
100

1000
10000
Hybridization 2

100000

Figure 5: The Oligo GEArray® exhibits excellent array-to-array reproducibility. XpressRef™ Human Universal Reference RNA (GA-004)
was converted to labeled cRNA target using the TrueLabeling-AMP™ Linear RNA Amplification Kit (GA-010). Equal amounts (2 µg) of
amplified product were hybridized to replicate Oligo GEArray® Human Microarrays. The Chemiluminescent Detection Kit (D-01) was used
to detect the presence of labeled target on the arrays. The raw intensity values for each gene from one array were plotted against those
values from the second array, and the data were fit to a straight line having a correlation factor (R2) of 0.9939.

Tel 888-503-3187 (USA)

301-682-9200

Fax 888-465-9859 (USA)

301-682-7300
SABiosciences
	
A complete gene expression profiling experiment requires the validation of microarray results by
real-time PCR (or an alternative method). Verification by real-time PCR should yield a closely matched gene
expression profile (70-90% agreement) to that observed with the microarray in order to regard the data as
reliable. Figure 6 illustrates the results of a gene expression profiling experiment in which the cancer-related
gene expression was compared between samples from two different breast cancer cell lines. The results obtained
with the Oligo GEArray® were confirmed by real-time PCR analysis of 84 genes using SABiosciences' RT2 RealTime™ Primer Sets. Using a fold-change threshold of 1.3, the relative gene expression changes for the cell samples
using the Oligo GEArray® and real-time PCR exhibited greater than 70% agreement, indicating a high degree of
reliability in the Oligo GEArray® results.
A
MCF7

B
2.5

MDA-MD-231

2.0

RT2 Real-Time™ PCR

1.5
1.0
0.5
0.0
-0.5
-1.0
-1.5
-2.0
-2.5
-1.5

-1.0

-0.5
0
0.5
1.0
Oligo GEArray® Human Cancer Microarray

1.5

Figure 6: The Oligo GEArray® demonstrates good correlation with real-time PCR results. RNA (3 µg) from two different of human breast
cancer cell lines, MCF7 and MDA-231, was converted to labeled cRNA target with the TrueLabeling-AMP™ RNA Linear RNA Amplification
Kit (GA-010). Triplicate samples of labeled target (6 µg) were hybridized to separate Human Oligo GEArray® Cancer Microarrays (OHS-802).
Sample array images are shown in Panel A. RNA (7 ng) from each cell line was also converted into first strand cDNA. Each cDNA sample
was used in multiple PCR reactions (n=5) of 84 genes represented by the microarray using RT2 Real-Time™ PCR Primer Sets. A ratio of relative gene expression between the two cell lines was calculated for each gene. The results determined with the two different experimental
methods are plotted against one another in Panel B. This result demonstrates a good agreement between the data sets indicating that the
GEArray® results are sufficiently reliable when compared to real-time PCR.

Discussion and Product Information
The Oligo GEArray® DNA microarray system offers an exceptional research solution for investigators
interested in studying gene expression profiles related to specific pathways or disease states. The pathwayfocused approach to array design, combined with the excellent performance characteristics described above,
affords researchers an effective and reliable tool for human, mouse, or rat gene expression discovery and
screening applications. Coupled with the straightforward procedure, the web-based data analysis software
and flexible protocol options allow the easy integration of the Oligo GEArray® platform into any laboratory.
SABiosciences offers a variety of products complimentary to the Oligo GEArray® line, including an ArrayGrade™
Total RNA Isolation Kit, RT2 Real-Time™ Primer Sets, instrument-specific master mixes, and other real-time
PCR reagents. A list of available microarrays is shown on the next page. Visit www.SABiosciences.com for more
information and a complete product catalog.

Email support@SABiosciences.com

Web www.SABiosciences.com
Pathway-Focused Oligo GEArray® Microarrays.
For a complete listing, visit www.SABiosciences.com/ArrayList.php
Pathway / Topic Focus
Alzheimer’s Disease
Angiogenesis
Apoptosis
Atherosclerosis
Autoimmune and Inflammatory Response  
Breast Cancer Biomarkers
Cancer
Cancer PathwayFinder™
Cardiovascular Disease Biomarkers
Cell Cycle
Cell Surface Markers
Chemokines and Receptors
Common Cytokines
Diabetes
DNA Damage Signaling Pathway
Endothelial Cell Biology
Extracellular Matrix and Adhesion Molecules
Genome Stability / DNA Repair
Hematology/Immunology
Hematopoietic Stem Cells and Hematopoiesis
HIV Infection and Host Response
Hypoxia Signaling Pathway
Inflammatory Cytokines and Receptors
Innate and Adaptive Immune Responses
Insulin Signaling Pathway
Interferon α,β Response
JAK / STAT Signaling Pathway
Neurogenesis and Neural Stem Cells
Neuroscience-1 Ion Channels and Transporters
Neurotransmitter Receptors and Regulators
Neurotrophins and Receptors
NFkB Signaling Pathway
Notch Signaling Pathway
Nuclear Receptors  Coregulators
Obesity
Osteogenesis
p53 Signaling Pathway
PI3K-AKT Signaling Pathway
Prostate Cancer Biomarkers
Signal Transduction PathwayFinder™
Stem Cell
Stress Response to Cellular Damage
T-cell and B-cell Activation
TGFβ / BMP Signaling Pathway
Th1-Th2-Th3
Toll-Like Receptor Signaling Pathway
Toxicology and Drug Resistance
Tumor Metastasis
WNT Signaling Pathway

HybPlate Format
Human
EHS-057
EHS-024
EHS-012
EHS-803
EHS-402
EHS-802
EHS-033
EHS-037
EHS-020

EHS-021

EHS-015
EHS-013
EHS-042
EHS-801

888-503-3187 (USA)
301-682-9200
888-465-9859 (USA)
301-682-7300
support@SABiosciences.com
www.SABiosciences.com

EMM-024
EMM-012

Rat
ERN-024.2
ERN-012.2

EMM-803

EMM-033
ERN-020
EMM-022
EMM-021

EMM-015
EMM-013

EHS-032
EHS-011

EMM-032
EMM-011.2
EMM-052

EHS-039
EHS-404

EMM-039
EMM-404

EHS-060

EMM-060

EHS-025
EHS-059
EHS-056

ERN-015.2

EMM-059

EHS-026
EHS-027
EHS-058
EHS-403
EHS-014
EHS-405

EHS-035
EHS-034
EHS-018.2
EHS-401
EHS-028
EHS-043

Contact us for more information on
Oligo GEArrays®:
Phone: 	
		
Fax:	
		
Email:	
Web:	

Mouse

HybTube Format

ERN-032
ERN-011.2

ERN-404
ERN-060
ERN-031

EMM-026

ERN-026

EMM-058

ERN-058

EMM-014
EMM-405

ERN-014.2

EMM-034
EMM-018.2
EMM-401
EMM-043

ERN-401
ERN-029

Human
OHS-057
OHS-024
OHS-012
OHS-038
OHS-803
OHS-402
OHS-802
OHS-033
OHS-037
OHS-020
OHS-055
OHS-022
OHS-021
OHS-029
OHS-015
OHS-013
OHS-042
OHS-801
OHS-054
OHS-051
OHS-032
OHS-011
OHS-052
OHS-030
OHS-039
OHS-404
OHS-036
OHS-060
OHS-031
OHS-025
OHS-059
OHS-056
OHS-026
OHS-027
OHS-058
OHS-403
OHS-014
OHS-405
OHS-053
OHS-035
OHS-034
OHS-018.2
OHS-401
OHS-028
OHS-043

Mouse

Rat

OMM-024
OMM-012
OMM-038
OMM-803

ORN-024.2
ORN-012.2

OMM-033
OMM-037
OMM-020
OMM-055
OMM-022
OMM-021
OMM-023
OMM-029
OMM-015
OMM-013
OMM-042

ORN-020
ORN-022
ORN-021
ORN-029
ORN-015.2
ORN-013

OMM-054
OMM-032
OMM-011
OMM-052
OMM-030
OMM-016
OMM-039
OMM-404
OMM-036
OMM-060
OMM-031
OMM-025
OMM-059
OMM-056
OMM-017
OMM-026
OMM-027
OMM-058

ORN-032
ORN-011.2

OMM-014
OMM-405
OMM-019
OMM-053
OMM-035
OMM-034
OMM-018.2
OMM-401
OMM-028
OMM-043

ORN-014.2

ORN-404
ORN-060
ORN-031
ORN-025

ORN-026
ORN-027
ORN-058

ORN-035
ORN-034
ORN-018
ORN-401
ORN-028
ORN-043

Free Training!
Attend one of our Web Seminars to learn
more about Oligo GEArray® Methods:
www.SABiosciences.com/seminarlist.php

Contenu connexe

Tendances

Sequential Automation of RNA and DNA preps on the same QIAcube instrument
Sequential Automation of RNA and DNA preps on the same QIAcube instrumentSequential Automation of RNA and DNA preps on the same QIAcube instrument
Sequential Automation of RNA and DNA preps on the same QIAcube instrumentQIAGEN
 
miScript Single Cell Poster
miScript Single Cell PostermiScript Single Cell Poster
miScript Single Cell PosterQIAGEN
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...QIAGEN
 
Genetic engineering
Genetic  engineeringGenetic  engineering
Genetic engineeringArunima Sur
 
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...QIAGEN
 
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...Zachary Smith
 
Assessment of Y chromosome degradation level using the Investigator® Quantipl...
Assessment of Y chromosome degradation level using the Investigator® Quantipl...Assessment of Y chromosome degradation level using the Investigator® Quantipl...
Assessment of Y chromosome degradation level using the Investigator® Quantipl...QIAGEN
 
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...eventi-ITBbari
 
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...Merck Life Sciences
 
Next-Generation Sequencing Commercial Milestones Infographic
Next-Generation Sequencing Commercial Milestones InfographicNext-Generation Sequencing Commercial Milestones Infographic
Next-Generation Sequencing Commercial Milestones InfographicQIAGEN
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsMerck Life Sciences
 
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...Thermo Fisher Scientific
 
Evolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsEvolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsKBI Biopharma
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Integrated DNA Technologies
 
Technology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationTechnology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationMilliporeSigma
 
Validation of anti niv igm capture elisa version#1
Validation of anti niv igm capture elisa version#1Validation of anti niv igm capture elisa version#1
Validation of anti niv igm capture elisa version#1krishgen
 
A High Throughput TaqMan CFTR Mutation Genotyping Workflow
A High Throughput TaqMan CFTR Mutation Genotyping WorkflowA High Throughput TaqMan CFTR Mutation Genotyping Workflow
A High Throughput TaqMan CFTR Mutation Genotyping WorkflowThermo Fisher Scientific
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesMerck Life Sciences
 

Tendances (19)

Sequential Automation of RNA and DNA preps on the same QIAcube instrument
Sequential Automation of RNA and DNA preps on the same QIAcube instrumentSequential Automation of RNA and DNA preps on the same QIAcube instrument
Sequential Automation of RNA and DNA preps on the same QIAcube instrument
 
Poster-microRNA Quantitation_Keystone 2008
Poster-microRNA Quantitation_Keystone 2008Poster-microRNA Quantitation_Keystone 2008
Poster-microRNA Quantitation_Keystone 2008
 
miScript Single Cell Poster
miScript Single Cell PostermiScript Single Cell Poster
miScript Single Cell Poster
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
 
Genetic engineering
Genetic  engineeringGenetic  engineering
Genetic engineering
 
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...
 
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...
NEBNext Ultra DNA for Illumina NGS (ChIP-seq and HLA)_Biomek FXP Automated Wo...
 
Assessment of Y chromosome degradation level using the Investigator® Quantipl...
Assessment of Y chromosome degradation level using the Investigator® Quantipl...Assessment of Y chromosome degradation level using the Investigator® Quantipl...
Assessment of Y chromosome degradation level using the Investigator® Quantipl...
 
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...
Ernesto Picardi – Bioinformatica e genomica comparata: nuove strategie sperim...
 
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
 
Next-Generation Sequencing Commercial Milestones Infographic
Next-Generation Sequencing Commercial Milestones InfographicNext-Generation Sequencing Commercial Milestones Infographic
Next-Generation Sequencing Commercial Milestones Infographic
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
 
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...
Digital PCR for soybean GMO detection on the OpenArray Platform: a case study...
 
Evolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsEvolution of mAb Downstream Platforms
Evolution of mAb Downstream Platforms
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
 
Technology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing PurificationTechnology Trends in Bioprocessing Purification
Technology Trends in Bioprocessing Purification
 
Validation of anti niv igm capture elisa version#1
Validation of anti niv igm capture elisa version#1Validation of anti niv igm capture elisa version#1
Validation of anti niv igm capture elisa version#1
 
A High Throughput TaqMan CFTR Mutation Genotyping Workflow
A High Throughput TaqMan CFTR Mutation Genotyping WorkflowA High Throughput TaqMan CFTR Mutation Genotyping Workflow
A High Throughput TaqMan CFTR Mutation Genotyping Workflow
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and Peptides
 

Similaire à Dna microarrays

MyGo Pro - das Original! Nur erhältlich bei LTF Labortechnik
MyGo Pro - das Original! Nur erhältlich bei LTF LabortechnikMyGo Pro - das Original! Nur erhältlich bei LTF Labortechnik
MyGo Pro - das Original! Nur erhältlich bei LTF LabortechnikLTF Labortechnik GmbH & Co. KG
 
Isac 2010 Poster Jay 042910 Final
Isac 2010 Poster Jay 042910 FinalIsac 2010 Poster Jay 042910 Final
Isac 2010 Poster Jay 042910 Finaljoropab1
 
Protein Microarrays: Approaches to Printing
Protein Microarrays: Approaches to PrintingProtein Microarrays: Approaches to Printing
Protein Microarrays: Approaches to PrintingSCHOTT
 
A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...Thermo Fisher Scientific
 
Expanding Your Research Capabilities Using Targeted NGS
Expanding Your Research Capabilities Using Targeted NGSExpanding Your Research Capabilities Using Targeted NGS
Expanding Your Research Capabilities Using Targeted NGSIntegrated DNA Technologies
 
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...Ilya Klabukov
 
Axiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAxiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAffymetrix
 
Microarray validation
Microarray validationMicroarray validation
Microarray validationElsa von Licy
 
Technical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the GuideTechnical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
 
Improved Reagents & Methods for Target Enrichment in Next Generation Sequencing
Improved Reagents & Methods for Target Enrichment in Next Generation SequencingImproved Reagents & Methods for Target Enrichment in Next Generation Sequencing
Improved Reagents & Methods for Target Enrichment in Next Generation SequencingIntegrated DNA Technologies
 
Detection of transgenic canola (Roundup Ready® - Monsanto)
Detection of transgenic canola (Roundup Ready® - Monsanto)Detection of transgenic canola (Roundup Ready® - Monsanto)
Detection of transgenic canola (Roundup Ready® - Monsanto)claudio iannetta
 
AUTOMATION IN SEROLOGY.pptx educational
AUTOMATION IN SEROLOGY.pptx  educationalAUTOMATION IN SEROLOGY.pptx  educational
AUTOMATION IN SEROLOGY.pptx educationalaryajayakottarathil
 
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposalGenomeInABottle
 
whole-genome-sequencing-guide-small-genomes.pdf.pdf
whole-genome-sequencing-guide-small-genomes.pdf.pdfwhole-genome-sequencing-guide-small-genomes.pdf.pdf
whole-genome-sequencing-guide-small-genomes.pdf.pdfCRISTIANALONSORODRIG1
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...GenomeInABottle
 
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-Seq
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-SeqNUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-Seq
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-SeqHimanshu Sethi
 

Similaire à Dna microarrays (20)

MyGo Pro - das Original! Nur erhältlich bei LTF Labortechnik
MyGo Pro - das Original! Nur erhältlich bei LTF LabortechnikMyGo Pro - das Original! Nur erhältlich bei LTF Labortechnik
MyGo Pro - das Original! Nur erhältlich bei LTF Labortechnik
 
Isac 2010 Poster Jay 042910 Final
Isac 2010 Poster Jay 042910 FinalIsac 2010 Poster Jay 042910 Final
Isac 2010 Poster Jay 042910 Final
 
Protein Microarrays: Approaches to Printing
Protein Microarrays: Approaches to PrintingProtein Microarrays: Approaches to Printing
Protein Microarrays: Approaches to Printing
 
Chigot poster2007
Chigot poster2007Chigot poster2007
Chigot poster2007
 
A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...
 
Expanding Your Research Capabilities Using Targeted NGS
Expanding Your Research Capabilities Using Targeted NGSExpanding Your Research Capabilities Using Targeted NGS
Expanding Your Research Capabilities Using Targeted NGS
 
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
Next Generation Diagnostics: Potential Clinical Applications of Illumina’sTec...
 
Axiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAxiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping Arrays
 
Microarray validation
Microarray validationMicroarray validation
Microarray validation
 
Technical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the GuideTechnical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the Guide
 
Improved Reagents & Methods for Target Enrichment in Next Generation Sequencing
Improved Reagents & Methods for Target Enrichment in Next Generation SequencingImproved Reagents & Methods for Target Enrichment in Next Generation Sequencing
Improved Reagents & Methods for Target Enrichment in Next Generation Sequencing
 
Detection of transgenic canola (Roundup Ready® - Monsanto)
Detection of transgenic canola (Roundup Ready® - Monsanto)Detection of transgenic canola (Roundup Ready® - Monsanto)
Detection of transgenic canola (Roundup Ready® - Monsanto)
 
AUTOMATION IN SEROLOGY.pptx educational
AUTOMATION IN SEROLOGY.pptx  educationalAUTOMATION IN SEROLOGY.pptx  educational
AUTOMATION IN SEROLOGY.pptx educational
 
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
 
whole-genome-sequencing-guide-small-genomes.pdf.pdf
whole-genome-sequencing-guide-small-genomes.pdf.pdfwhole-genome-sequencing-guide-small-genomes.pdf.pdf
whole-genome-sequencing-guide-small-genomes.pdf.pdf
 
Plant Pathogen Booklet
Plant Pathogen BookletPlant Pathogen Booklet
Plant Pathogen Booklet
 
05 costa
05 costa05 costa
05 costa
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
 
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-Seq
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-SeqNUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-Seq
NUGEN-X-Gen_2011_poster_trancriptome_sequencing_RNA-Seq
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
 

Plus de Elsa von Licy

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Elsa von Licy
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiElsa von Licy
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
NeuropsychophysiologieElsa von Licy
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)Elsa von Licy
 
C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuroElsa von Licy
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01Elsa von Licy
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercicesElsa von Licy
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pElsa von Licy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsElsa von Licy
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesElsa von Licy
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiantsElsa von Licy
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficaceElsa von Licy
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introElsa von Licy
 

Plus de Elsa von Licy (20)

Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
Styles of Scientific Reasoning, Scientific Practices and Argument in Science ...
 
Strategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfiStrategie Decisions Incertitude Actes conference fnege xerfi
Strategie Decisions Incertitude Actes conference fnege xerfi
 
Rainville pierre
Rainville pierreRainville pierre
Rainville pierre
 
Neuropsychophysiologie
NeuropsychophysiologieNeuropsychophysiologie
Neuropsychophysiologie
 
L agressivite en psychanalyse (21 pages 184 ko)
L agressivite en psychanalyse (21 pages   184 ko)L agressivite en psychanalyse (21 pages   184 ko)
L agressivite en psychanalyse (21 pages 184 ko)
 
C1 clef pour_la_neuro
C1 clef pour_la_neuroC1 clef pour_la_neuro
C1 clef pour_la_neuro
 
Hemostase polycop
Hemostase polycopHemostase polycop
Hemostase polycop
 
Antiphilos
AntiphilosAntiphilos
Antiphilos
 
Vuillez jean philippe_p01
Vuillez jean philippe_p01Vuillez jean philippe_p01
Vuillez jean philippe_p01
 
Spr ue3.1 poly cours et exercices
Spr ue3.1   poly cours et exercicesSpr ue3.1   poly cours et exercices
Spr ue3.1 poly cours et exercices
 
Plan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 pPlan de cours all l1 l2l3m1m2 p
Plan de cours all l1 l2l3m1m2 p
 
M2 bmc2007 cours01
M2 bmc2007 cours01M2 bmc2007 cours01
M2 bmc2007 cours01
 
Feuilletage
FeuilletageFeuilletage
Feuilletage
 
Chapitre 1
Chapitre 1Chapitre 1
Chapitre 1
 
Biophy
BiophyBiophy
Biophy
 
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutionsBioph pharm 1an-viscosit-des_liquides_et_des_solutions
Bioph pharm 1an-viscosit-des_liquides_et_des_solutions
 
Poly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicalesPoly histologie-et-embryologie-medicales
Poly histologie-et-embryologie-medicales
 
Methodes travail etudiants
Methodes travail etudiantsMethodes travail etudiants
Methodes travail etudiants
 
Atelier.etude.efficace
Atelier.etude.efficaceAtelier.etude.efficace
Atelier.etude.efficace
 
There is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_introThere is no_such_thing_as_a_social_science_intro
There is no_such_thing_as_a_social_science_intro
 

Dna microarrays

  • 1. White Paper Oligo GEArrays®: The Pathway-Focused DNA Microarray System for Every Laboratory By Heather Fox-Brashears, George Quellhorst, Raymond Blanchard, Bill Wang and Sean Yu SABiosciences 6951 Executive Way Frederick, MD 21703 +1 (301) 682-9200 Phone +1 (301) 682-7300 Fax www.SABiosciences.com heatherf@SABiosciences.net ABSTRACT This paper describes the technology and performance characteristics of the Oligo GEArray® DNA microarray system. Oligo GEArrays® are an effective alternative to genome-wide microarrays, in that each array is designed to profile expression of a focused gene panel from a particular biological pathway or disease state. The data presented in this paper substantiates the sensitivity, reproducibility, and reliability of this innovative approach to microarray design. The Oligo GEArray’s® flexible protocol options, ease-of-use, and adaptability to any laboratory setting provide researchers with a robust tool for routine use of microarray technology in everyday experiments.
  • 2. Pathway-Focused Oligo GEArrays® Introduction to Microarray Technology and Oligo GEArrays® Microarray technology utilizes RNA from cells, tissue, and other biological source materials to simultaneously determine the expression levels of many genes. Microarrays are composed of a set of distinct, gene-specific, nucleic acid probes immobilized on a solid support. During a microarray experiment, RNA is enzymatically converted to labeled cDNA (complementary DNA) or cRNA, and then hybridized to the immobilized nucleic acid probe. The labeled target bound at each gene-specific spot is typically detected using chemiluminescent, fluorescent, or radioactive methods. The signal produced at each spot is representative of the amount of message in the original RNA sample. Advances in DNA microarray technology have facilitated genome-wide expression profiling with whole genome microarrays available from companies such as Affymetrix, Agilent or Illumina. While these microarrays provide a solution for discovery-based research endeavors, the large amount of data produced from genome-wide arrays requires the use of specialized software and daunting analysis procedures. SABiosciences pathway-focused, lower-density Oligo GEArray® microarray system provides a more economical and productive alternative for monitoring a focused panel of genes in a particular biological pathway or disease state. Oligo GEArrays® are comprised of a nylon membrane support spotted with gene-specific 60-mer oligos for up to 440 different genes. Oligo GEArrays® use as little as 10 pg of total RNA, with a chemiluminescence detection method. No special equipment is required for the Oligo GEArray® platform, facilitating its easy adoption into any biological research laboratory. These arrays offer comparable performance to high-density microarray formats while enabling hypothesis-driven experimental design, relevant data acquisition, and efficient data analysis. Oligo GEArray Characteristics The Oligo GEArray® product platform combines expertly designed pathway-specific microarrays and advanced oligonucleotide probe design with a streamlined labeling, hybridization, and detection protocol (Figure 1). The distinct advantages of the Oligo GEArray® system are outlined in Table 1. With the combined benefits of the membranes, reagents, uncomplicated protocol, and the GEArray® Analysis Suite Software, the Oligo GEArray® product line provides a complete and convenient microarray experiment package for any laboratory. Table 1: Features and Benefits of the Oligo GEArray® System Focused Array Design Lower-density (113-440 genes) arrays designed by biological pathway or disease state for relevant data acquisition Excellent Quality Manufacturing Carefully-designed mRNA 3’ end biased 60-mer oligonucleotide probes (Median distance ~160 bases from 3’ end) on a positively-charged nylon membrane with noncontact printing method (10 nL deposition volume) Easy Target Labeling One-tube proprietary IVT-based linear RNA amplification labeling kit using 0.1 to 3 µg of total RNA Various Detection Method Single color / channel chemiluminescent detection or X-ray film Express Protocol With the HybPlate Array format, you can easily process up to 32 arrays in one day Straightforward Data Analysis Software Web-based software available by subscription Tel 888-503-3187 (USA) 301-682-9200 Fax 888-465-9859 (USA) 301-682-7300
  • 3. SABiosciences HybPlate Express Protocol (Single Day Experiment) Standard HybTube Protocol (Two Day Experiment) 3 hours How It Works 3 hours 3.5 hours in Thermoshaker Overnight in Hyb Oven 0.75 hours 1.5 hours 0.5 hours 0.5 hours Preparation of Labeled cRNA with TrueLabelingAMP™ 2.0 Start with as little as 0.1 - 3.0 µg of Total RNA Amplify Labeled cRNA Target Hybridization and Washing Simply add cRNA target to the GEArray and follow the easy hybridization and wash steps. ce urfa yS Arra Signal Development Detection is as simple as developing a Western Blot using chemiluminescence. Image Aquisition Use a CCD-camera system to capture chemiluminescence. You can also use X-ray film and a standard desktop scanner. ® Analysis with GEArray Expression Analysis Suite Auto-align the gene table for your arrays to the captured image, select your analysis parameters, and go! Graphical and tabulated differential gene expression data is at your fingertips. Figure 1: Outline of the Oligo GEArray® experimental procedure Oligo GEArrays are composed of 113-440 gene-specific 60-mer oligos that have been rigorously evaluated for specificity, sequence complexity, secondary structure, melting temperature, GC content, and distance to 3’ end of transcript. The oligo probes are immobilized on a positively charged, three-dimensional nylon membrane. The nylon membrane matrix offers distinct advantages over impermeable surfaces such as chips and glass slides, including larger probe immobilization and increased hybridization and detection area. When combined with an optimally formulated hybridization solution and sensitive chemiluminescent detection, the Oligo GEArray membrane maximizes both hybridization efficiency and signal generation. The choice of two different target labeling kits is an integral part of the Oligo GEArray platform. The TrueLabeling-AMP™ 2.0 linear amplification and labeling kit is a universal target labeling method specifically designed to convert total RNA to amplified and labeled cRNA (Step 1, Figure 1). Based on standard in vitro transcription based methods, the TrueLabeling-AMP™ 2.0 procedure requires fewer enzymatic reactions, only one purification step, and a significantly shorter protocol as compared to traditional procedures. The biotinylated cRNA target contains the same 3’ biased sequences as the gene-specific oligonucleotides printed on the array to Email support@SABiosciences.com Web www.SABiosciences.com
  • 4. Pathway-Focused Oligo GEArrays® enhance efficient hybridization and maximize signal. Only 0.1 to 3 µg of total RNA starting material is required for the TrueLabeling-AMP 2.0 kit to produce sufficient cRNA for hybridization. When using a consistent amount of cRNA in the hybridization step, differing amounts of total RNA can be utilized to produce similar microarray results (Figure 2). The TrueLabeling-PicoAMP™ two-round amplification and labeling kit is designed for very small samples with as little as 100 picograms of RNA (10 cells), and provides comparable results to the standard one-round True Labeling-AMP 2.0. In Figure 3, a comparison is shown between microarray results with varying amounts of input RNA in the two-round TrueLabeling-PicoAMP™ kit, and results obtained with the one-round True Labeling-AMP kit. The TrueLabeling-PicoAMP™ kit offers an excellent solution for laboratories interested in performing microarray studies on sources of limited RNA, such as laser capture microdissection (LCM), Formalin-Fixed Paraffin Embedded (FFPE), or Fine Needle Aspiration Biopsy (FNAB) samples. Normalized Signal Intensity (SI) 4.00 Log(SI) from 100ng RT-IVT input 3.00 2.00 1.00 0.00 -1.00 -2.00 -3.00 -4.00 y = 1.0102x - 0.1532 2 R = 0.9738 -5.00 -6.00 -6.00 -4.00 -2.00 0.00 2.00 Log(SI) from 3ug RT-IVT input 4.00 Figure 2: Biotinylated cRNA synthesized from different amounts of total RNA produce similar array results. A constant amount (2 µg) of cRNA generated from differing amounts of total RNA (listed above) was hybridized to separate Oligo GEArray Human Tumor Metastasis Microarrays (HybTube format, catalog number OHS-028) for 18 hours at 60oC. Hybridization, washing, and chemiluminescent detection were performed as outlined in the User Manual. A good correlation was observed between the normalized signal intensities obtained with different total RNA inputs. 1.50 Normalized Signal Intensity (SI) Log(SI) from 500pg total RNA 1.00 0.50 0.00 -0.50 -1.00 y = 0.9064x + 0.0513 2 R = 0.9336 -1.50 -1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Log(SI) from 500ng total RNA Figure 3: Similar microarray performance is observed with 500 pg total RNA starting material with the TrueLabeling-PicoAMP™ kit as compared to 500 ng total RNA starting material with the TrueLabeling-AMP™ 2.0 kit. Human XpressRef™ Total RNA (500 pg) was used in the TrueLabeling-PicoAMP™ procedure as outlined in the User Manual. The 1-round TrueLabeling-AMP™ 2.0 amplification and labeling procedure was performed as outlined in the User Manual with 500 ng of the Human XpressRef™ Total RNA. For the hybridization step, 2 µg of each cRNA target was hybridized to separate Oligo GEArray® Human Tumor Metastasis Microarrays (HybTube format, catalog number OHS-028). Hybridization with 2-round cRNA produced a similar pattern and comparable percent present call to the 1-round cRNA. A good correlation in normalized signal intensity was observed between the two labeling methods. Tel 888-503-3187 (USA) 301-682-9200 Fax 888-465-9859 (USA) 301-682-7300
  • 5. SABiosciences The Oligo GEArray® hybridization protocol, array formats, and detection methods also offer flexibility and processing options for every laboratory. The traditional HybTube array format is designed for use with the standard rotisserie-style hybridization ovens. The HybPlate format is ideal for high-throughput applications, allowing the processing of up to 32 arrays in one day with the use of SABiosciences' specialized GEArray® Express Thermoshaker. The GEArray® chemiluminescent detection system, optimized for use with the nylon membrane matrix, offers excellent sensitivity, wide dynamic range (up to 4 orders of magnitude), and versatile image acquisition options. Chemiluminescent detection provides comparable or better sensitivity and signal as compared to radioactive detection methods, without the worry of radioactive waste disposal and precautionary laboratory measures. The array images can be captured using a cooled CCD camera (for best results) or simply with X-ray film and the use of a desktop scanner. When used with autoradiography film, chemiluminescent detection methods are generally more sensitive than radioactivity. Array data analysis is facilitated through the use of SABiosciences' GEArray® Expression Analysis Suite web-based software. This subscription-based software offers automated, array-specific analytical functions as well as various analysis tools including scatter plots and hierarchical clustering. The Oligo GEArray® is a user-friendly, efficient, and focused DNA microarray tool that offers superior pathway-focused solutions for gene expression studies. The straightforward protocol includes a cRNA amplification and labeling portion that can be completed in as little as 2.5 hours. In addition, the protocol provides flexible hybridization options that include a 1-day express procedure (HybPlate format only), and a simple and safe chemiluminescent detection. Oligo GEArrays® provide a convenient, cost-effective, sensitive, and pathway-focused alternative to genome-wide microarrays. Oligo GEArray Performance: Sensitivity, Dynamic Range, Reproducibility, and Reliability Typical performance parameters for microarray validation include sensitivity and dynamic range, reproducibility, and reliability (compatibility with real-time PCR results). The Oligo GEArray® system affords excellent sensitivity, a wide dynamic range (up to 4 orders of magnitude), robust reproducibility, and good correlation with real-time PCR experiments. Oligo GEArrays® offer similar or better performance as compared to popular genome-wide array systems (Table 2). Table 2: Typical System Performance (*based on published Affymetrix technical notes) Oligo GEArray® Affymetrix™ GeneChip®* Sensitivity As low as 10 fM synthetic target 125 fM Linear Dynamic Range 3 orders of magnitude 3 orders of magnitude Specificity 60-mers provide superior specificity as compared to shorter probes 25-mer probes provide less sensitivity that 60-mer or 70-mer probes Reproducibility ~ 10% CV 10-15% CV Sample Input 10 pg – 3 µg total RNA At least 100 ng RNA Email support@SABiosciences.com Web www.SABiosciences.com
  • 6. Pathway-Focused Oligo GEArrays® To address the qualities of sensitivity and dynamic range, known quantities of labeled synthetic RNA target were spiked into a labeled human RNA sample for the performance of a series of hybridization experiments (Figure 4). The Oligo GEArray® exhibits a low-limit of detection in the 10 fM range, as demonstrated by detection of the target at a spiking ratio of 1:20,000,000. This performance level indicates that the Oligo GEArray® is an excellent tool for studying low abundance transcripts (less than 10 copies per cell); however, the wide linear dynamic range allows for the simultaneous, accurate detection of both high and low abundance messages. Performance determined by titration of synthetic target 100000 Raw Intensity R2 = 0.9969 10000 1000 100 noise level 10 0.00 0.01 0.10 1.00 10.00 100.00 Luciferase cRNA (pM) Figure 4: The Oligo GEArray exhibits a high level of sensitivity and wide linear dynamic range. A firefly luciferase in vitro transcript was converted to labeled cRNA target using the TrueLabeling-AMP method. Different known amounts of the target (10 fM to 10 pM) were mixed with a constant amount of labeled cRNA target generated from XpressRef™ Human Universal Reference Total RNA (GA-004). Each mixture of labeled cRNA target was hybridized to replicate Oligo GEArray® Human Microarrays. The luciferase gene raw signal intensity was plotted versus the quantity of labeled luciferase cRNA. These results demonstrate that the Oligo GEArray® can detect as little as 10 fM labeled target with a linear dynamic range of four orders of magnitude (from 0.01 pM to 10 pM). Oligo GEArrays® are manufactured utilizing an advanced, non-contact printing technology that ensures excellent array print quality and reproducibility. Technical replicates within an experiment generally yield coefficient of variation values (CVs) of less than 10%. Figure 5 illustrates a representative comparison between the results of duplicate Oligo GEArrays®. The results demonstrate a high degree of correlation between the data sets; thus indicating that the Oligo GEArray® system is a robust, reproducible method to reliably detect small, yet biologically significant changes in gene expression. 100000 Hybridization 1 R2 = 0.9939 10000 1000 100 100 1000 10000 Hybridization 2 100000 Figure 5: The Oligo GEArray® exhibits excellent array-to-array reproducibility. XpressRef™ Human Universal Reference RNA (GA-004) was converted to labeled cRNA target using the TrueLabeling-AMP™ Linear RNA Amplification Kit (GA-010). Equal amounts (2 µg) of amplified product were hybridized to replicate Oligo GEArray® Human Microarrays. The Chemiluminescent Detection Kit (D-01) was used to detect the presence of labeled target on the arrays. The raw intensity values for each gene from one array were plotted against those values from the second array, and the data were fit to a straight line having a correlation factor (R2) of 0.9939. Tel 888-503-3187 (USA) 301-682-9200 Fax 888-465-9859 (USA) 301-682-7300
  • 7. SABiosciences A complete gene expression profiling experiment requires the validation of microarray results by real-time PCR (or an alternative method). Verification by real-time PCR should yield a closely matched gene expression profile (70-90% agreement) to that observed with the microarray in order to regard the data as reliable. Figure 6 illustrates the results of a gene expression profiling experiment in which the cancer-related gene expression was compared between samples from two different breast cancer cell lines. The results obtained with the Oligo GEArray® were confirmed by real-time PCR analysis of 84 genes using SABiosciences' RT2 RealTime™ Primer Sets. Using a fold-change threshold of 1.3, the relative gene expression changes for the cell samples using the Oligo GEArray® and real-time PCR exhibited greater than 70% agreement, indicating a high degree of reliability in the Oligo GEArray® results. A MCF7 B 2.5 MDA-MD-231 2.0 RT2 Real-Time™ PCR 1.5 1.0 0.5 0.0 -0.5 -1.0 -1.5 -2.0 -2.5 -1.5 -1.0 -0.5 0 0.5 1.0 Oligo GEArray® Human Cancer Microarray 1.5 Figure 6: The Oligo GEArray® demonstrates good correlation with real-time PCR results. RNA (3 µg) from two different of human breast cancer cell lines, MCF7 and MDA-231, was converted to labeled cRNA target with the TrueLabeling-AMP™ RNA Linear RNA Amplification Kit (GA-010). Triplicate samples of labeled target (6 µg) were hybridized to separate Human Oligo GEArray® Cancer Microarrays (OHS-802). Sample array images are shown in Panel A. RNA (7 ng) from each cell line was also converted into first strand cDNA. Each cDNA sample was used in multiple PCR reactions (n=5) of 84 genes represented by the microarray using RT2 Real-Time™ PCR Primer Sets. A ratio of relative gene expression between the two cell lines was calculated for each gene. The results determined with the two different experimental methods are plotted against one another in Panel B. This result demonstrates a good agreement between the data sets indicating that the GEArray® results are sufficiently reliable when compared to real-time PCR. Discussion and Product Information The Oligo GEArray® DNA microarray system offers an exceptional research solution for investigators interested in studying gene expression profiles related to specific pathways or disease states. The pathwayfocused approach to array design, combined with the excellent performance characteristics described above, affords researchers an effective and reliable tool for human, mouse, or rat gene expression discovery and screening applications. Coupled with the straightforward procedure, the web-based data analysis software and flexible protocol options allow the easy integration of the Oligo GEArray® platform into any laboratory. SABiosciences offers a variety of products complimentary to the Oligo GEArray® line, including an ArrayGrade™ Total RNA Isolation Kit, RT2 Real-Time™ Primer Sets, instrument-specific master mixes, and other real-time PCR reagents. A list of available microarrays is shown on the next page. Visit www.SABiosciences.com for more information and a complete product catalog. Email support@SABiosciences.com Web www.SABiosciences.com
  • 8. Pathway-Focused Oligo GEArray® Microarrays. For a complete listing, visit www.SABiosciences.com/ArrayList.php Pathway / Topic Focus Alzheimer’s Disease Angiogenesis Apoptosis Atherosclerosis Autoimmune and Inflammatory Response   Breast Cancer Biomarkers Cancer Cancer PathwayFinder™ Cardiovascular Disease Biomarkers Cell Cycle Cell Surface Markers Chemokines and Receptors Common Cytokines Diabetes DNA Damage Signaling Pathway Endothelial Cell Biology Extracellular Matrix and Adhesion Molecules Genome Stability / DNA Repair Hematology/Immunology Hematopoietic Stem Cells and Hematopoiesis HIV Infection and Host Response Hypoxia Signaling Pathway Inflammatory Cytokines and Receptors Innate and Adaptive Immune Responses Insulin Signaling Pathway Interferon α,β Response JAK / STAT Signaling Pathway Neurogenesis and Neural Stem Cells Neuroscience-1 Ion Channels and Transporters Neurotransmitter Receptors and Regulators Neurotrophins and Receptors NFkB Signaling Pathway Notch Signaling Pathway Nuclear Receptors Coregulators Obesity Osteogenesis p53 Signaling Pathway PI3K-AKT Signaling Pathway Prostate Cancer Biomarkers Signal Transduction PathwayFinder™ Stem Cell Stress Response to Cellular Damage T-cell and B-cell Activation TGFβ / BMP Signaling Pathway Th1-Th2-Th3 Toll-Like Receptor Signaling Pathway Toxicology and Drug Resistance Tumor Metastasis WNT Signaling Pathway HybPlate Format Human EHS-057 EHS-024 EHS-012 EHS-803 EHS-402 EHS-802 EHS-033 EHS-037 EHS-020 EHS-021 EHS-015 EHS-013 EHS-042 EHS-801 888-503-3187 (USA) 301-682-9200 888-465-9859 (USA) 301-682-7300 support@SABiosciences.com www.SABiosciences.com EMM-024 EMM-012 Rat ERN-024.2 ERN-012.2 EMM-803 EMM-033 ERN-020 EMM-022 EMM-021 EMM-015 EMM-013 EHS-032 EHS-011 EMM-032 EMM-011.2 EMM-052 EHS-039 EHS-404 EMM-039 EMM-404 EHS-060 EMM-060 EHS-025 EHS-059 EHS-056 ERN-015.2 EMM-059 EHS-026 EHS-027 EHS-058 EHS-403 EHS-014 EHS-405 EHS-035 EHS-034 EHS-018.2 EHS-401 EHS-028 EHS-043 Contact us for more information on Oligo GEArrays®: Phone: Fax: Email: Web: Mouse HybTube Format ERN-032 ERN-011.2 ERN-404 ERN-060 ERN-031 EMM-026 ERN-026 EMM-058 ERN-058 EMM-014 EMM-405 ERN-014.2 EMM-034 EMM-018.2 EMM-401 EMM-043 ERN-401 ERN-029 Human OHS-057 OHS-024 OHS-012 OHS-038 OHS-803 OHS-402 OHS-802 OHS-033 OHS-037 OHS-020 OHS-055 OHS-022 OHS-021 OHS-029 OHS-015 OHS-013 OHS-042 OHS-801 OHS-054 OHS-051 OHS-032 OHS-011 OHS-052 OHS-030 OHS-039 OHS-404 OHS-036 OHS-060 OHS-031 OHS-025 OHS-059 OHS-056 OHS-026 OHS-027 OHS-058 OHS-403 OHS-014 OHS-405 OHS-053 OHS-035 OHS-034 OHS-018.2 OHS-401 OHS-028 OHS-043 Mouse Rat OMM-024 OMM-012 OMM-038 OMM-803 ORN-024.2 ORN-012.2 OMM-033 OMM-037 OMM-020 OMM-055 OMM-022 OMM-021 OMM-023 OMM-029 OMM-015 OMM-013 OMM-042 ORN-020 ORN-022 ORN-021 ORN-029 ORN-015.2 ORN-013 OMM-054 OMM-032 OMM-011 OMM-052 OMM-030 OMM-016 OMM-039 OMM-404 OMM-036 OMM-060 OMM-031 OMM-025 OMM-059 OMM-056 OMM-017 OMM-026 OMM-027 OMM-058 ORN-032 ORN-011.2 OMM-014 OMM-405 OMM-019 OMM-053 OMM-035 OMM-034 OMM-018.2 OMM-401 OMM-028 OMM-043 ORN-014.2 ORN-404 ORN-060 ORN-031 ORN-025 ORN-026 ORN-027 ORN-058 ORN-035 ORN-034 ORN-018 ORN-401 ORN-028 ORN-043 Free Training! Attend one of our Web Seminars to learn more about Oligo GEArray® Methods: www.SABiosciences.com/seminarlist.php